+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Topical Drug Delivery Market - Global Forecast to 2030- Product Image
Topical Drug Delivery Market - Global Forecast to 2030- Product Image
Sale

Topical Drug Delivery Market - Global Forecast to 2030

  • PDF Icon

    Report

  • 194 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 4829843
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Topical Drug Delivery Market grew from USD 122.73 billion in 2024 to USD 131.50 billion in 2025. It is expected to continue growing at a CAGR of 6.88%, reaching USD 182.98 billion by 2030.

Topical drug delivery has evolved into a pivotal segment of pharmaceutical innovation, providing targeted therapeutic effects directly at the site of application. As patients increasingly seek non-invasive, localized treatment options with reduced systemic exposure, this mode of administration has gained unprecedented momentum. Our exploration begins by examining the fundamental drivers behind this growth: improvements in formulation science, rising prevalence of chronic dermatological and pain-related conditions, and the demand for user-friendly treatment modalities. By addressing these critical factors, this summary establishes the groundwork for understanding how topical delivery has transitioned from a niche offering to a cornerstone of modern pharmacotherapy.

Transformative Shifts Reshaping the Market Dynamics

The landscape of topical drug delivery has undergone transformative shifts driven by scientific breakthroughs and changing patient expectations. Advances in nanocarrier systems, including liposomes and solid lipid nanoparticles, have enhanced skin penetration and controlled release, while the integration of microneedle and iontophoretic technologies has broadened the scope of deliverable molecules. Concurrently, personalized medicine trends are reshaping formulations to match individual genetic and physiological profiles. These innovations are complemented by regulatory adaptations that streamline approval pathways for novel topical applications. Together, these forces have accelerated the incorporation of sophisticated delivery mechanisms into mainstream clinical practice, redefining therapeutic possibilities.

Cumulative Impact of New US Tariffs on 2025 Supply Chains

The implementation of new United States tariff measures in 2025 has exerted a cumulative impact on raw material sourcing, manufacturing costs, and supply chain resilience. Increased duties on key excipients and packaging components originating from affected trade partners have prompted formulators to secure alternative suppliers or adapt compositions to mitigate cost pressures. At the same time, contract manufacturers have revisited their logistics strategies, exploring domestic production or near-shoring to preserve margins. These shifts have also influenced contract research timelines, as lead times for imported reagents lengthen and regulatory bodies scrutinize ingredient provenance more closely. Taken together, these developments underscore the need for agile procurement and adaptable supply chain frameworks.

Key Insights from Market Segmentation Analysis

An in-depth look at how the market is segmented reveals nuanced growth opportunities across multiple dimensions. When products are categorized by drug type, non-steroidal therapies such as immunosuppressants and nonsteroidal anti-inflammatory drugs coexist with steroidal options including anabolic steroids and topical corticosteroids, each addressing distinct therapeutic needs. Examining formulation, one finds liquid vehicles-from emulsions to solutions and suspensions-alongside semisolid forms like creams, gels, ointments and pastes, as well as solid modalities such as patches and powders. Therapeutic categories span dermatology, where acne treatments, eczema care and psoriasis therapy dominate, to infectious disease management featuring antifungal medications and antiviral treatments, through ophthalmology with antibiotic treatments and antihistamines, into pain management via arthritis pain relief and muscle relaxants, and finally respiratory care led by asthma inhalers and bronchodilators. End-user analysis covers ambulatory surgery centers, homecare settings, hospitals and clinics with specialty clinics embedded within, and retail pharmacies, while age group segmentation distinguishes adult, geriatric and pediatric applications.

Critical Regional Trends Influencing Growth Trajectories

Regional behavior continues to shape strategic priorities. In the Americas, robust healthcare infrastructure and consumer awareness have driven broad adoption of topical therapies for both chronic and acute conditions, supported by comprehensive reimbursement frameworks. Across Europe, Middle East & Africa, diverse regulatory landscapes and varying access models challenge manufacturers to tailor market entry approaches, yet the demand for high-value, premium formulations remains strong. Meanwhile, Asia-Pacific stands out for its rapid urbanization and rising healthcare expenditures, with local R&D investments accelerating the development of novel delivery platforms and fostering partnerships between multinational corporations and regional stakeholders.

Competitive Landscape and Leading Industry Players

Competitive dynamics reveal a spectrum of capabilities among leading innovators and specialized providers. Companies like Absorption Systems LLC and Custom Converting, Inc. excel in preclinical and formulation testing services, whereas Bayer AG, GlaxoSmithKline PLC and Novartis International AG leverage extensive portfolios across therapeutic categories to optimize topical pipelines. Specialized dermatology players such as Galderma Laboratories, L.P. and Hisamitsu Pharmaceutical Co., Inc. focus on targeted skin care solutions, while contract development firms including MedPharm Ltd. and The Lubrizol Corporation drive formulation science forward. In parallel, global generics producers like Cipla Limited, Glenmark Pharmaceuticals Limited and Mylan N.V. expand access through cost-effective alternatives, and integrated healthcare conglomerates such as Johnson & Johnson Services, Inc. and Pfizer Inc. maintain broad platform strategies that integrate topical applications within larger treatment regimens.

Actionable Recommendations for Industry Leadership

Industry leaders should embrace several actionable strategies to secure competitive advantage. First, invest in modular manufacturing and flexible production lines to adapt swiftly to formulation variations and tariff-induced supply disruptions. Second, prioritize partnerships with regional CMOs and CROs to enhance local market penetration and accelerate time-to-market. Third, deepen R&D efforts around advanced penetration enhancers and personalized delivery systems, leveraging data analytics to align product designs with patient preferences. Furthermore, strengthening engagement with regulatory authorities can streamline approvals for innovative platforms. Lastly, integrate value-added services-such as digital adherence tracking and telemedicine support-to differentiate offerings and build long-term customer loyalty.

Conclusion and Strategic Outlook

In conclusion, the topical drug delivery sector stands at the intersection of technological innovation, regulatory evolution and shifting market forces. By understanding the drivers of growth-from advanced nanocarriers and microneedles to regional market nuances and tariff impacts-decision-makers can navigate complexity with confidence. Strategic investments in agile manufacturing, collaborative partnerships and patient-centric solutions will be pivotal in capturing emerging opportunities. As stakeholders align their priorities with these insights, the path forward promises not only enhanced therapeutic outcomes but also sustainable business performance.

Market Segmentation & Coverage

This research report categorizes the Topical Drug Delivery Market to forecast the revenues and analyze trends in each of the following sub-segmentations:

  • Non-Steroidal
    • Immunosuppressants
    • Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
  • Steroidal
    • Anabolic Steroids
    • Topical Corticosteroids
  • Liquid Formulations
    • Emulsions
    • Solutions
    • Suspensions
  • Semisolid Formulations
    • Creams
    • Gels
    • Ointments
    • Pastels
  • Solid Formulations
    • Patches
    • Powders
  • Dermatology
    • Acne Treatments
    • Eczema Care
    • Psoriasis Therapy
  • Infectious Diseases
    • Antifungal Medications
    • Antiviral Treatments
  • Ophthalmology
    • Antibiotic Treatments
    • Antihistamines
  • Pain Management
    • Arthritis Pain Relief
    • Muscle Relaxants
  • Respiratory Diseases
    • Asthma Inhalers
    • Bronchodilators
  • Ambulatory Surgery Centers
  • Homecare Settings
  • Hospitals and Clinics
    • Specialty Clinics
  • Retail Pharmacies
  • Adult
  • Geriatric
  • Pediatric

This research report categorizes the Topical Drug Delivery Market to forecast the revenues and analyze trends in each of the following sub-regions:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

This research report categorizes the Topical Drug Delivery Market to delves into recent significant developments and analyze trends in each of the following companies:

  • Absorption Systems LLC
  • Bayer AG
  • Cipla Limited
  • Custom Converting, Inc.
  • Galderma Laboratories, L.P.
  • GlaxoSmithKline PLC
  • Glenmark Pharmaceuticals Limited
  • Hisamitsu Pharmaceutical Co., Inc.
  • Johnson & Johnson Services, Inc.
  • MedPharm Ltd.
  • Mylan N.V.
  • Novartis AG
  • Novartis International AG
  • Pfizer Inc.
  • The Lubrizol Corporation

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Topical Drug Delivery Market, by Drug Type
8.1. Introduction
8.2. Non-Steroidal
8.2.1. Immunosuppressants
8.2.2. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
8.3. Steroidal
8.3.1. Anabolic Steroids
8.3.2. Topical Corticosteroids
9. Topical Drug Delivery Market, by Formulation
9.1. Introduction
9.2. Liquid Formulations
9.2.1. Emulsions
9.2.2. Solutions
9.2.3. Suspensions
9.3. Semisolid Formulations
9.3.1. Creams
9.3.2. Gels
9.3.3. Ointments
9.3.4. Pastels
9.4. Solid Formulations
9.4.1. Patches
9.4.2. Powders
10. Topical Drug Delivery Market, by Therapeutic Category
10.1. Introduction
10.2. Dermatology
10.2.1. Acne Treatments
10.2.2. Eczema Care
10.2.3. Psoriasis Therapy
10.3. Infectious Diseases
10.3.1. Antifungal Medications
10.3.2. Antiviral Treatments
10.4. Ophthalmology
10.4.1. Antibiotic Treatments
10.4.2. Antihistamines
10.5. Pain Management
10.5.1. Arthritis Pain Relief
10.5.2. Muscle Relaxants
10.6. Respiratory Diseases
10.6.1. Asthma Inhalers
10.6.2. Bronchodilators
11. Topical Drug Delivery Market, by End User
11.1. Introduction
11.2. Ambulatory Surgery Centers
11.3. Homecare Settings
11.4. Hospitals and Clinics
11.4.1. Specialty Clinics
11.5. Retail Pharmacies
12. Topical Drug Delivery Market, by Age Group
12.1. Introduction
12.2. Adult
12.3. Geriatric
12.4. Pediatric
13. Americas Topical Drug Delivery Market
13.1. Introduction
13.2. Argentina
13.3. Brazil
13.4. Canada
13.5. Mexico
13.6. United States
14. Asia-Pacific Topical Drug Delivery Market
14.1. Introduction
14.2. Australia
14.3. China
14.4. India
14.5. Indonesia
14.6. Japan
14.7. Malaysia
14.8. Philippines
14.9. Singapore
14.10. South Korea
14.11. Taiwan
14.12. Thailand
14.13. Vietnam
15. Europe, Middle East & Africa Topical Drug Delivery Market
15.1. Introduction
15.2. Denmark
15.3. Egypt
15.4. Finland
15.5. France
15.6. Germany
15.7. Israel
15.8. Italy
15.9. Netherlands
15.10. Nigeria
15.11. Norway
15.12. Poland
15.13. Qatar
15.14. Russia
15.15. Saudi Arabia
15.16. South Africa
15.17. Spain
15.18. Sweden
15.19. Switzerland
15.20. Turkey
15.21. United Arab Emirates
15.22. United Kingdom
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Absorption Systems LLC
16.3.2. Bayer AG
16.3.3. Cipla Limited
16.3.4. Custom Converting, Inc.
16.3.5. Galderma Laboratories, L.P.
16.3.6. GlaxoSmithKline PLC
16.3.7. Glenmark Pharmaceuticals Limited
16.3.8. Hisamitsu Pharmaceutical Co., Inc.
16.3.9. Johnson & Johnson Services, Inc.
16.3.10. MedPharm Ltd.
16.3.11. Mylan N.V.
16.3.12. Novartis AG
16.3.13. Novartis International AG
16.3.14. Pfizer Inc.
16.3.15. The Lubrizol Corporation
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. TOPICAL DRUG DELIVERY MARKET MULTI-CURRENCY
FIGURE 2. TOPICAL DRUG DELIVERY MARKET MULTI-LANGUAGE
FIGURE 3. TOPICAL DRUG DELIVERY MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY DRUG TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY DRUG TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY FORMULATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY FORMULATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC CATEGORY, 2024 VS 2030 (%)
FIGURE 12. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC CATEGORY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY AGE GROUP, 2024 VS 2030 (%)
FIGURE 16. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS TOPICAL DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS TOPICAL DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC TOPICAL DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC TOPICAL DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. TOPICAL DRUG DELIVERY MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. TOPICAL DRUG DELIVERY MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. TOPICAL DRUG DELIVERY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY NON-STEROIDAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY IMMUNOSUPPRESSANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY NON-STEROIDAL, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY STEROIDAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY ANABOLIC STEROIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY TOPICAL CORTICOSTEROIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY STEROIDAL, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY EMULSIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY SUSPENSIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMISOLID FORMULATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY CREAMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY GELS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY OINTMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY PASTELS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMISOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY PATCHES, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY POWDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC CATEGORY, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY DERMATOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY ACNE TREATMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY ECZEMA CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY PSORIASIS THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY DERMATOLOGY, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY ANTIFUNGAL MEDICATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY ANTIVIRAL TREATMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY OPHTHALMOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY ANTIBIOTIC TREATMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY ANTIHISTAMINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY OPHTHALMOLOGY, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY ARTHRITIS PAIN RELIEF, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY MUSCLE RELAXANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY RESPIRATORY DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY ASTHMA INHALERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY BRONCHODILATORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY RESPIRATORY DISEASES, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY ADULT, BY REGION, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS TOPICAL DRUG DELIVERY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS TOPICAL DRUG DELIVERY MARKET SIZE, BY NON-STEROIDAL, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS TOPICAL DRUG DELIVERY MARKET SIZE, BY STEROIDAL, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS TOPICAL DRUG DELIVERY MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 69. AMERICAS TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMISOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 70. AMERICAS TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 71. AMERICAS TOPICAL DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC CATEGORY, 2018-2030 (USD MILLION)
TABLE 72. AMERICAS TOPICAL DRUG DELIVERY MARKET SIZE, BY DERMATOLOGY, 2018-2030 (USD MILLION)
TABLE 73. AMERICAS TOPICAL DRUG DELIVERY MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 74. AMERICAS TOPICAL DRUG DELIVERY MARKET SIZE, BY OPHTHALMOLOGY, 2018-2030 (USD MILLION)
TABLE 75. AMERICAS TOPICAL DRUG DELIVERY MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 76. AMERICAS TOPICAL DRUG DELIVERY MARKET SIZE, BY RESPIRATORY DISEASES, 2018-2030 (USD MILLION)
TABLE 77. AMERICAS TOPICAL DRUG DELIVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 78. AMERICAS TOPICAL DRUG DELIVERY MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 79. AMERICAS TOPICAL DRUG DELIVERY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 80. AMERICAS TOPICAL DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 81. ARGENTINA TOPICAL DRUG DELIVERY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 82. ARGENTINA TOPICAL DRUG DELIVERY MARKET SIZE, BY NON-STEROIDAL, 2018-2030 (USD MILLION)
TABLE 83. ARGENTINA TOPICAL DRUG DELIVERY MARKET SIZE, BY STEROIDAL, 2018-2030 (USD MILLION)
TABLE 84. ARGENTINA TOPICAL DRUG DELIVERY MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 85. ARGENTINA TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 86. ARGENTINA TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMISOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 87. ARGENTINA TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 88. ARGENTINA TOPICAL DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC CATEGORY, 2018-2030 (USD MILLION)
TABLE 89. ARGENTINA TOPICAL DRUG DELIVERY MARKET SIZE, BY DERMATOLOGY, 2018-2030 (USD MILLION)
TABLE 90. ARGENTINA TOPICAL DRUG DELIVERY MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 91. ARGENTINA TOPICAL DRUG DELIVERY MARKET SIZE, BY OPHTHALMOLOGY, 2018-2030 (USD MILLION)
TABLE 92. ARGENTINA TOPICAL DRUG DELIVERY MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 93. ARGENTINA TOPICAL DRUG DELIVERY MARKET SIZE, BY RESPIRATORY DISEASES, 2018-2030 (USD MILLION)
TABLE 94. ARGENTINA TOPICAL DRUG DELIVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 95. ARGENTINA TOPICAL DRUG DELIVERY MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 96. ARGENTINA TOPICAL DRUG DELIVERY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 97. BRAZIL TOPICAL DRUG DELIVERY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 98. BRAZIL TOPICAL DRUG DELIVERY MARKET SIZE, BY NON-STEROIDAL, 2018-2030 (USD MILLION)
TABLE 99. BRAZIL TOPICAL DRUG DELIVERY MARKET SIZE, BY STEROIDAL, 2018-2030 (USD MILLION)
TABLE 100. BRAZIL TOPICAL DRUG DELIVERY MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 101. BRAZIL TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 102. BRAZIL TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMISOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 103. BRAZIL TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 104. BRAZIL TOPICAL DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC CATEGORY, 2018-2030 (USD MILLION)
TABLE 105. BRAZIL TOPICAL DRUG DELIVERY MARKET SIZE, BY DERMATOLOGY, 2018-2030 (USD MILLION)
TABLE 106. BRAZIL TOPICAL DRUG DELIVERY MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 107. BRAZIL TOPICAL DRUG DELIVERY MARKET SIZE, BY OPHTHALMOLOGY, 2018-2030 (USD MILLION)
TABLE 108. BRAZIL TOPICAL DRUG DELIVERY MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 109. BRAZIL TOPICAL DRUG DELIVERY MARKET SIZE, BY RESPIRATORY DISEASES, 2018-2030 (USD MILLION)
TABLE 110. BRAZIL TOPICAL DRUG DELIVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 111. BRAZIL TOPICAL DRUG DELIVERY MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 112. BRAZIL TOPICAL DRUG DELIVERY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 113. CANADA TOPICAL DRUG DELIVERY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 114. CANADA TOPICAL DRUG DELIVERY MARKET SIZE, BY NON-STEROIDAL, 2018-2030 (USD MILLION)
TABLE 115. CANADA TOPICAL DRUG DELIVERY MARKET SIZE, BY STEROIDAL, 2018-2030 (USD MILLION)
TABLE 116. CANADA TOPICAL DRUG DELIVERY MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 117. CANADA TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 118. CANADA TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMISOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 119. CANADA TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 120. CANADA TOPICAL DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC CATEGORY, 2018-2030 (USD MILLION)
TABLE 121. CANADA TOPICAL DRUG DELIVERY MARKET SIZE, BY DERMATOLOGY, 2018-2030 (USD MILLION)
TABLE 122. CANADA TOPICAL DRUG DELIVERY MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 123. CANADA TOPICAL DRUG DELIVERY MARKET SIZE, BY OPHTHALMOLOGY, 2018-2030 (USD MILLION)
TABLE 124. CANADA TOPICAL DRUG DELIVERY MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 125. CANADA TOPICAL DRUG DELIVERY MARKET SIZE, BY RESPIRATORY DISEASES, 2018-2030 (USD MILLION)
TABLE 126. CANADA TOPICAL DRUG DELIVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 127. CANADA TOPICAL DRUG DELIVERY MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 128. CANADA TOPICAL DRUG DELIVERY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 129. MEXICO TOPICAL DRUG DELIVERY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 130. MEXICO TOPICAL DRUG DELIVERY MARKET SIZE, BY NON-STEROIDAL, 2018-2030 (USD MILLION)
TABLE 131. MEXICO TOPICAL DRUG DELIVERY MARKET SIZE, BY STEROIDAL, 2018-2030 (USD MILLION)
TABLE 132. MEXICO TOPICAL DRUG DELIVERY MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 133. MEXICO TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 134. MEXICO TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMISOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 135. MEXICO TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 136. MEXICO TOPICAL DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC CATEGORY, 2018-2030 (USD MILLION)
TABLE 137. MEXICO TOPICAL DRUG DELIVERY MARKET SIZE, BY DERMATOLOGY, 2018-2030 (USD MILLION)
TABLE 138. MEXICO TOPICAL DRUG DELIVERY MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 139. MEXICO TOPICAL DRUG DELIVERY MARKET SIZE, BY OPHTHALMOLOGY, 2018-2030 (USD MILLION)
TABLE 140. MEXICO TOPICAL DRUG DELIVERY MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 141. MEXICO TOPICAL DRUG DELIVERY MARKET SIZE, BY RESPIRATORY DISEASES, 2018-2030 (USD MILLION)
TABLE 142. MEXICO TOPICAL DRUG DELIVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 143. MEXICO TOPICAL DRUG DELIVERY MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 144. MEXICO TOPICAL DRUG DELIVERY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 145. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 146. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY NON-STEROIDAL, 2018-2030 (USD MILLION)
TABLE 147. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY STEROIDAL, 2018-2030 (USD MILLION)
TABLE 148. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 149. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 150. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMISOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 151. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 152. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC CATEGORY, 2018-2030 (USD MILLION)
TABLE 153. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY DERMATOLOGY, 2018-2030 (USD MILLION)
TABLE 154. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 155. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY OPHTHALMOLOGY, 2018-2030 (USD MILLION)
TABLE 156. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 157. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY RESPIRATORY DISEASES, 2018-2030 (USD MILLION)
TABLE 158. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 159. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 160. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 161. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 162. ASIA-PACIFIC TOPICAL DRUG DELIVERY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 163. ASIA-PACIFIC TOPICAL DRUG DELIVERY MARKET SIZE, BY NON-STEROIDAL, 2018-2030 (USD MILLION)
TABLE 164. ASIA-PACIFIC TOPICAL DRUG DELIVERY MARKET SIZE, BY STEROIDAL, 2018-2030 (USD MILLION)
TABLE 165. ASIA-PACIFIC TOPICAL DRUG DELIVERY MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 166. ASIA-PACIFIC TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 167. ASIA-PACIFIC TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMISOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 168. ASIA-PACIFIC TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 169. ASIA-PACIFIC TOPICAL DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC CATEGORY, 2018-2030 (USD MILLION)
TABLE 170. ASIA-PACIFIC TOPICAL DRUG DELIVERY MARKET SIZE, BY DERMATOLOGY, 2018-2030 (USD MILLION)
TABLE 171. ASIA-PACIFIC TOPICAL DRUG DELIVERY MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 172. ASIA-PACIFIC TOPICAL DRUG DELIVERY MARKET SIZE, BY OPHTHALMOLOGY, 2018-2030 (USD MILLION)
TABLE 173. ASIA-PACIFIC TOPICAL DRUG DELIVERY MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 174. ASIA-PACIFIC TOPICAL DRUG DELIVERY MARKET SIZE, BY RESPIRATORY DISEASES, 2018-2030 (USD MILLION)
TABLE 175. ASIA-PACIFIC TOPICAL DRUG DELIVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 176. ASIA-PACIFIC TOPICAL DRUG DELIVERY MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 177. ASIA-PACIFIC TOPICAL DRUG DELIVERY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 178. ASIA-PACIFIC TOPICAL DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 179. AUSTRALIA TOPICAL DRUG DELIVERY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 180. AUSTRALIA TOPICAL DRUG DELIVERY MARKET SIZE, BY NON-STEROIDAL, 2018-2030 (USD MILLION)
TABLE 181. AUSTRALIA TOPICAL DRUG DELIVERY MARKET SIZE, BY STEROIDAL, 2018-2030 (USD MILLION)
TABLE 182. AUSTRALIA TOPICAL DRUG DELIVERY MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 183. AUSTRALIA TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 184. AUSTRALIA TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMISOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 185. AUSTRALIA TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 186. AUSTRALIA TOPICAL DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC CATEGORY, 2018-2030 (USD MILLION)
TABLE 187. AUSTRALIA TOPICAL DRUG DELIVERY MARKET SIZE, BY DERMATOLOGY, 2018-2030 (USD MILLION)
TABLE 188. AUSTRALIA TOPICAL DRUG DELIVERY MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 189. AUSTRALIA TOPICAL DRUG DELIVERY MARKET SIZE, BY OPHTHALMOLOGY, 2018-2030 (USD MILLION)
TABLE 190. AUSTRALIA TOPICAL DRUG DELIVERY MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 191. AUSTRALIA TOPICAL DRUG DELIVERY MARKET SIZE, BY RESPIRATORY DISEASES, 2018-2030 (USD MILLION)
TABLE 192. AUSTRALIA TOPICAL DRUG DELIVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 193. AUSTRALIA TOPICAL DRUG DELIVERY MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 194. AUSTRALIA TOPICAL DRUG DELIVERY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 195. CHINA TOPICAL DRUG DELIVERY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 196. CHINA TOPICAL DRUG DELIVERY MARKET SIZE, BY NON-STEROIDAL, 2018-2030 (USD MILLION)
TABLE 197. CHINA TOPICAL DRUG DELIVERY MARKET SIZE, BY STEROIDAL, 2018-2030 (USD MILLION)
TABLE 198. CHINA TOPICAL DRUG DELIVERY MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 199. CHINA TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 200. CHINA TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMISOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 201. CHINA TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 202. CHINA TOPICAL DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC CATEGORY, 2018-2030 (USD MILLION)
TABLE 203. CHINA TOPICAL DRUG DELIVERY MARKET SIZE, BY DERMATOLOGY, 2018-2030 (USD MILLION)
TABLE 204. CHINA TOPICAL DRUG DELIVERY MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 205. CHINA TOPICAL DRUG DELIVERY MARKET SIZE, BY OPHTHALMOLOGY, 2018-2030 (USD MILLION)
TABLE 206. CHINA TOPICAL DRUG DELIVERY MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 207. CHINA TOPICAL DRUG DELIVERY MARKET SIZE, BY RESPIRATORY DISEASES, 2018-2030 (USD MILLION)
TABLE 208. CHINA TOPICAL DRUG DELIVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 209. CHINA TOPICAL DRUG DELIVERY MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 210. CHINA TOPICAL DRUG DELIVERY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 211. INDIA TOPICAL DRUG DELIVERY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 212. INDIA TOPICAL DRUG DELIVERY MARKET SIZE, BY NON-STEROIDAL, 2018-2030 (USD MILLION)
TABLE 213. INDIA TOPICAL DRUG DELIVERY MARKET SIZE, BY STEROIDAL, 2018-2030 (USD MILLION)
TABLE 214. INDIA TOPICAL DRUG DELIVERY MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 215. INDIA TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 216. INDIA TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMISOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 217. INDIA TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 218. INDIA TOPICAL DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC CATEGORY, 2018-2030 (USD MILLION)
TABLE 219. INDIA TOPICAL DRUG DELIVERY MARKET SIZE, BY DERMATOLOGY, 2018-2030 (USD MILLION)
TABLE 220. INDIA TOPICAL DRUG DELIVERY MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 221. INDIA TOPICAL DRUG DELIVERY MARKET SIZE, BY OPHTHALMOLOGY, 2018-2030 (USD MILLION)
TABLE 222. INDIA TOPICAL DRUG DELIVERY MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 223. INDIA TOPICAL DRUG DELIVERY MARKET SIZE, BY RESPIRATORY DISEASES, 2018-2030 (USD MILLION)
TABLE 224. INDIA TOPICAL DRUG DELIVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 225. INDIA TOPICAL DRUG DELIVERY MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 226. INDIA TOPICAL DRUG DELIVERY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 227. INDONESIA TOPICAL DRUG DELIVERY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 228. INDONESIA TOPICAL DRUG DELIVERY MARKET SIZE, BY NON-STEROIDAL, 2018-2030 (USD MILLION)
TABLE 229. INDONESIA TOPICAL DRUG DELIVERY MARKET SIZE, BY STEROIDAL, 2018-2030 (USD MILLION)
TABLE 230. INDONESIA TOPICAL DRUG DELIVERY MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 231. INDONESIA TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 232. INDONESIA TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMISOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 233. INDONESIA TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 234. INDONESIA TOPICAL DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC CATEGORY, 2018-2030 (USD MILLION)
TABLE 235. INDONESIA TOPICAL DRUG DELIVERY MARKET SIZE, BY DERMATOLOGY, 2018-2030 (USD MILLION)
TABLE 236. INDONESIA TOPICAL DRUG DELIVERY MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 237. INDONESIA TOPICAL DRUG DELIVERY MARKET SIZE, BY OPHTHALMOLOGY, 2018-2030 (USD MILLION)
TABLE 238. INDONESIA TOPICAL DRUG DELIVERY MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 239. INDONESIA TOPICAL DRUG DELIVERY MARKET SIZE, BY RESPIRATORY DISEASES, 2018-2030 (USD MILLION)
TABLE 240. INDONESIA TOPICAL DRUG DELIVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 241. INDONESIA TOPICAL DRUG DELIVERY MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 242. INDONESIA TOPICAL DRUG DELIVERY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 243. JAPAN TOPICAL DRUG DELIVERY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 244. JAPAN TOPICAL DRUG DELIVERY MARKET SIZE, BY NON-STEROIDAL, 2018-2030 (USD MILLION)
TABLE 245. JAPAN TOPICAL DRUG DELIVERY MARKET SIZE, BY STEROIDAL, 2018-2030 (USD MILLION)
TABLE 246. JAPAN TOPICAL DRUG DELIVERY MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 247. JAPAN TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 248. JAPAN TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMISOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 249. JAPAN TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 250. JAPAN TOPICAL DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC CATEGORY, 2018-2030 (USD MILLION)
TABLE 251. JAPAN TOPICAL DRUG DELIVERY MARKET SIZE, BY DERMATOLOGY, 2018-2030 (USD MILLION)
TABLE 252. JAPAN TOPICAL DRUG DELIVERY MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 253. JAPAN TOPICAL DRUG DELIVERY MARKET SIZE, BY OPHTHALMOLOGY, 2018-2030 (USD MILLION)
TABLE 254. JAPAN TOPICAL DRUG DELIVERY MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 255. JAPAN TOPICAL DRUG DELIVERY MARKET SIZE, BY RESPIRATORY DISEASES, 2018-2030 (USD MILLION)
TABLE 256. JAPAN TOPICAL DRUG DELIVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 257. JAPAN TOPICAL DRUG DELIVERY MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 258. JAPAN TOPICAL DRUG DELIVERY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 259. MALAYSIA TOPICAL DRUG DELIVERY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 260. MALAYSIA TOPICAL DRUG DELIVERY MARKET SIZE, BY NON-STEROIDAL, 2018-2030 (USD MILLION)
TABLE 261. MALAYSIA TOPICAL DRUG DELIVERY MARKET SIZE, BY STEROIDAL, 2018-2030 (USD MILLION)
TABLE 262. MALAYSIA TOPICAL DRUG DELIVERY MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 263. MALAYSIA TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 264. MALAYSIA TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMISOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 265. MALAYSIA TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 266. MALAYSIA TOPICAL DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC CATEGORY, 2018-2030 (USD MILLION)
TABLE 267. MALAYSIA TOPICAL DRUG DELIVERY MARKET SIZE, BY DERMATOLOGY, 2018-2030 (USD MILLION)
TABLE 268. MALAYSIA TOPICAL DRUG DELIVERY MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 269. MALAYSIA TOPICAL DRUG DELIVERY MARKET SIZE, BY OPHTHALMOLOGY, 2018-2030 (USD MILLION)
TABLE 270. MALAYSIA TOPICAL DRUG DELIVERY MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 271. MALAYSIA TOPICAL DRUG DELIVERY MARKET SIZE, BY RESPIRATORY DISEASES, 2018-2030 (USD MILLION)
TABLE 272. MALAYSIA TOPICAL DRUG DELIVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 273. MALAYSIA TOPICAL DRUG DELIVERY MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 274. MALAYSIA TOPICAL DRUG DELIVERY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 275. PHILIPPINES TOPICAL DRUG DELIVERY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 276. PHILIPPINES TOPICAL DRUG DELIVERY MARKET SIZE, BY NON-STEROIDAL, 2018-2030 (USD MILLION)
TABLE 277. PHILIPPINES TOPICAL DRUG DELIVERY MARKET SIZE, BY STEROIDAL, 2018-2030 (USD MILLION)
TABLE 278. PHILIPPINES TOPICAL DRUG DELIVERY MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 279. PHILIPPINES TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 280. PHILIPPINES TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMISOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 281. PHILIPPINES TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 282. PHILIPPINES TOPICAL DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC CATEGORY, 2018-2030 (USD MILLION)
TABLE 283. PHILIPPINES TOPICAL DRUG DELIVERY MARKET SIZE, BY DERMATOLOGY, 2018-2030 (USD MILLION)
TABLE 284. PHILIPPINES TOPICAL DRUG DELIVERY MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 285. PHILIPPINES TOPICAL DRUG DELIVERY MARKET SIZE, BY OPHTHALMOLOGY, 2018-2030 (USD MILLION)
TABLE 286. PHILIPPINES TOPICAL DRUG DELIVERY MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 287. PHILIPPINES TOPICAL DRUG DELIVERY MARKET SIZE, BY RESPIRATORY DISEASES, 2018-2030 (USD MILLION)
TABLE 288. PHILIPPINES TOPICAL DRUG DELIVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 289. PHILIPPINES TOPICAL DRUG DELIVERY MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 290. PHILIPPINES TOPICAL DRUG DELIVERY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 291. SINGAPORE TOPICAL DRUG DELIVERY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 292. SINGAPORE TOPICAL DRUG DELIVERY MARKET SIZE, BY NON-STEROIDAL, 2018-2030 (USD MILLION)
TABLE 293. SINGAPORE TOPICAL DRUG DELIVERY MARKET SIZE, BY STEROIDAL, 2018-2030 (USD MILLION)
TABLE 294. SINGAPORE TOPICAL DRUG DELIVERY MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 295. SINGAPORE TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 296. SINGAPORE TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMISOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 297. SINGAPORE TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 298. SINGAPORE TOPICAL DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC CATEGORY, 2018-2030 (USD MILLION)
TABLE 299. SINGAPORE TOPICAL DRUG DELIVERY MARKET SIZE, BY DERMATOLOGY, 2018-2030 (USD MILLION)
TABLE 300. SINGAPORE TOPICAL DRUG DELIVERY MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 301. SINGAPORE TOPICAL DRUG DELIVERY MARKET SIZE, BY OPHTHALMOLOGY, 2018-2030 (USD MILLION)
TABLE 302. SINGAPORE TOPICAL DRUG DELIVERY MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 303. SINGAPORE TOPICAL DRUG DELIVERY MARKET SIZE, BY RESPIRATORY DISEASES, 2018-2030 (USD MILLION)
TABLE 304. SINGAPORE TOPICAL DRUG DELIVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 305. SINGAPORE TOPICAL DRUG DELIVERY MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 306. SINGAPORE TOPICAL DRUG DELIVERY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 307. SOUTH KOREA TOPICAL DRUG DELIVERY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 308. SOUTH KOREA TOPICAL DRUG DELIVERY MARKET SIZE, BY NON-STEROIDAL, 2018-2030 (USD MILLION)
TABLE 309. SOUTH KOREA TOPICAL DRUG DELIVERY MARKET SIZE, BY STEROIDAL, 2018-2030 (USD MILLION)
TABLE 310. SOUTH KOREA TOPICAL DRUG DELIVERY MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 311. SOUTH KOREA TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 312. SOUTH KOREA TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMISOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 313. SOUTH KOREA TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 314. SOUTH KOREA TOPICAL DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC CATEGORY, 2018-2030 (USD MILLION)
TABLE 315. SOUTH KOREA TOPICAL DRUG DELIVERY MARKET SIZE, BY DERMATOLOGY, 2018-2030 (USD MILLION)
TABLE 316. SOUTH KOREA TOPICAL DRUG DELIVERY MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 317. SOUTH KOREA TOPICAL DRUG DELIVERY MARKET SIZE, BY OPHTHALMOLOGY, 2018-2030 (USD MILLION)
TABLE 318. SOUTH KOREA TOPICAL DRUG DELIVERY MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 319. SOUTH KOREA TOPICAL DRUG DELIVERY MARKET SIZE, BY RESPIRATORY DISEASES, 2018-2030 (USD MILLION)
TABLE 320. SOUTH KOREA TOPICAL DRUG DELIVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 321. SOUTH KOREA TOPICAL DRUG DELIVERY MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 322. SOUTH KOREA TOPICAL DRUG DELIVERY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 323. TAIWAN TOPICAL DRUG DELIVERY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 324. TAIWAN TOPICAL DRUG DELIVERY MARKET SIZE, BY NON-STEROIDAL, 2018-2030 (USD MILLION)
TABLE 325. TAIWAN TOPICAL DRUG DELIVERY MARKET SIZE, BY STEROIDAL, 2018-2030 (USD MILLION)
TABLE 326. TAIWAN TOPICAL DRUG DELIVERY MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 327. TAIWAN TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 328. TAIWAN TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMISOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 329. TAIWAN TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 330. TAIWAN TOPICAL DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC CATEGORY, 2018-2030 (

Companies Mentioned

  • Absorption Systems LLC
  • Bayer AG
  • Cipla Limited
  • Custom Converting, Inc.
  • Galderma Laboratories, L.P.
  • GlaxoSmithKline PLC
  • Glenmark Pharmaceuticals Limited
  • Hisamitsu Pharmaceutical Co., Inc.
  • Johnson & Johnson Services, Inc.
  • MedPharm Ltd.
  • Mylan N.V.
  • Novartis AG
  • Novartis International AG
  • Pfizer Inc.
  • The Lubrizol Corporation

Methodology

Loading
LOADING...

Related Topics

Related Reports

Topical Drugs Market Size, Share & Trends Analysis Report By Route Of Administration, By Type, By End Use, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Topical Drugs Market Size, Share & Trends Analysis Report By Route Of Administration, By Type, By End Use, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 100 Pages
  • Global
From
Topical Drug Delivery Market Market By Product, By Route Of Administration, Regional Outlook - Global Forecast up to 2030 - Product Image

Topical Drug Delivery Market Market By Product, By Route Of Administration, Regional Outlook - Global Forecast up to 2030

  • Report
  • 116 Pages
  • Global
From
Topical Drug Delivery - Global Strategic Business Report - Product Image

Topical Drug Delivery - Global Strategic Business Report

  • Report
  • 94 Pages
  • Global
From
Topical Drug Delivery Market Report 2025 - Product Image

Topical Drug Delivery Market Report 2025

  • Report
  • 200 Pages
  • Global
From

About the Topical Drug Delivery Market

The Topical Drug Delivery market is a subset of the larger Drug Delivery market, which focuses on the delivery of drugs to the body through various methods. Topical Drug Delivery involves the application of drugs to the skin, mucous membranes, or other external surfaces of the body. This method of drug delivery is advantageous because it allows for localized delivery of drugs, which can reduce systemic side effects and improve patient compliance. Additionally, topical drug delivery can be used to deliver drugs to specific areas of the body, such as the eyes, ears, and nose. The Topical Drug Delivery market is composed of a variety of companies, including Galderma, Mylan, and Perrigo. These companies specialize in the development and manufacture of topical drug delivery systems, such as creams, ointments, gels, and patches. Additionally, many of these companies offer services such as formulation development, clinical trial support, and regulatory affairs. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.